148 related articles for article (PubMed ID: 7857079)
21. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
22. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
[TBL] [Abstract][Full Text] [Related]
23. Treatment of secondary hyperparathyroidism in hemodialyzed patients with high-dose calcium carbonate without vitamin D3 supplements.
Teruel JL; Tenorio MT; Rodríguez JR; Marc n R; Orofino L; Rivera M; Ortuño J
Am J Nephrol; 1999; 19(3):428-32. PubMed ID: 10393383
[TBL] [Abstract][Full Text] [Related]
24. Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Lu KC; Yeung LK; Lin SH; Lin YF; Chu P
Am J Kidney Dis; 2003 Dec; 42(6):1221-7. PubMed ID: 14655194
[TBL] [Abstract][Full Text] [Related]
25. Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment.
Sanchez CP
Paediatr Drugs; 2003; 5(11):763-76. PubMed ID: 14580225
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis of secondary hyperparathyroidism.
Slatopolsky E; Delmez JA
Am J Kidney Dis; 1994 Feb; 23(2):229-36. PubMed ID: 8311080
[TBL] [Abstract][Full Text] [Related]
27. Low-dose alfacalcidol controls secondary hyperparathyroidism in predialysis chronic kidney disease.
Reichel H
Nephron Clin Pract; 2010; 114(4):c268-76. PubMed ID: 20090369
[TBL] [Abstract][Full Text] [Related]
28. Calcium balance and intact PTH variations during haemodiafiltration.
Argilés A; Mion CM
Nephrol Dial Transplant; 1995 Nov; 10(11):2083-9. PubMed ID: 8643172
[TBL] [Abstract][Full Text] [Related]
29. Acute effect of dialysate calcium concentration and intravenous vitamin D3 on the secretion of parathyroid hormone in hemodialysis patients.
Saha H; Pietilä K; Mustonen J; Pasternack A; Mörsky P
Clin Nephrol; 1992 Sep; 38(3):145-8. PubMed ID: 1395167
[TBL] [Abstract][Full Text] [Related]
30. Effect of the mode of calcitriol administration on PTH-ionized calcium relationship in uraemic patients with secondary hyperparathyroidism.
Caravaca F; Cubero JJ; Jimenez F; López JM; Aparicio A; Cid MC; Pizarro JL; Liso J; Santos I
Nephrol Dial Transplant; 1995; 10(5):665-70. PubMed ID: 7566580
[TBL] [Abstract][Full Text] [Related]
31. Effects of pamidronate and calcitriol on the set point of the parathyroid gland in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Huang CY; Zheng CM; Wu CC; Lo L; Lu KC; Chu P
Nephron Clin Pract; 2012; 122(3-4):93-101. PubMed ID: 23635416
[TBL] [Abstract][Full Text] [Related]
32. [Renal osteodystrophy Guidelines].
Messa P;
G Ital Nefrol; 2003; 20 Suppl 24():S83-95. PubMed ID: 14666505
[TBL] [Abstract][Full Text] [Related]
33. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
34. No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure.
Ardissino G; Schmitt CP; Bianchi ML; Daccò V; Claris-Appiani A; Mehls O
Kidney Int; 2000 Sep; 58(3):981-8. PubMed ID: 10972662
[TBL] [Abstract][Full Text] [Related]
35. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
Morio K; Koide K
Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid hormone during maintenance dialysis: influence of low calcium dialysate, plasma albumin and age.
Heaf JG; Løkkegård H
J Nephrol; 1998; 11(4):203-10. PubMed ID: 9702872
[TBL] [Abstract][Full Text] [Related]
37. Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients. Durham Renal Osteodystrophy Study Group.
Indridason OS; Quarles LD
Kidney Int; 2000 Jan; 57(1):282-92. PubMed ID: 10620210
[TBL] [Abstract][Full Text] [Related]
38. Long-term suppression of secondary hyperparathyroidism by intravenous 1 alpha-hydroxyvitamin D3 in patients on chronic hemodialysis.
Brandi L; Daugaard H; Tvedegaard E; Nielsen PK; Egsmose C; Storm T; Olgaard K
Am J Nephrol; 1992; 12(5):311-8. PubMed ID: 1488999
[TBL] [Abstract][Full Text] [Related]
39. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU
J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
[TBL] [Abstract][Full Text] [Related]
40. [What are the actual indications for a surgical parathiroidectomy?].
Torres PU
Nephrol Ther; 2005 Dec; 1 Suppl 4():S342-50. PubMed ID: 17373206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]